purchase customization

1 Study Coverage
1.1 Polio (Poliomyelitis) Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Polio (Poliomyelitis) Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Inactivated Polio Vaccine (IPV)
1.2.3 Oral Polio Vaccine (OPV)
1.3 Market by Application
1.3.1 Global Polio (Poliomyelitis) Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Research & Academic Laboratories
1.3.3 Pharmaceutical & Biotechnology Companies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Polio (Poliomyelitis) Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Polio (Poliomyelitis) Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Polio (Poliomyelitis) Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Polio (Poliomyelitis) Vaccines Sales by Region
2.4.1 Global Polio (Poliomyelitis) Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Polio (Poliomyelitis) Vaccines by Region (2023-2028)
2.5 Global Polio (Poliomyelitis) Vaccines Revenue by Region
2.5.1 Global Polio (Poliomyelitis) Vaccines Revenue by Region (2017-2022)
2.5.2 Global Polio (Poliomyelitis) Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Polio (Poliomyelitis) Vaccines Sales by Manufacturers
3.1.1 Global Top Polio (Poliomyelitis) Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Polio (Poliomyelitis) Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Polio (Poliomyelitis) Vaccines in 2021
3.2 Global Polio (Poliomyelitis) Vaccines Revenue by Manufacturers
3.2.1 Global Polio (Poliomyelitis) Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Polio (Poliomyelitis) Vaccines Revenue in 2021
3.3 Global Polio (Poliomyelitis) Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Polio (Poliomyelitis) Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Polio (Poliomyelitis) Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Polio (Poliomyelitis) Vaccines Sales by Type
4.1.1 Global Polio (Poliomyelitis) Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Polio (Poliomyelitis) Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Polio (Poliomyelitis) Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Polio (Poliomyelitis) Vaccines Revenue by Type
4.2.1 Global Polio (Poliomyelitis) Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Polio (Poliomyelitis) Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Polio (Poliomyelitis) Vaccines Price by Type
4.3.1 Global Polio (Poliomyelitis) Vaccines Price by Type (2017-2022)
4.3.2 Global Polio (Poliomyelitis) Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Polio (Poliomyelitis) Vaccines Sales by Application
5.1.1 Global Polio (Poliomyelitis) Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global Polio (Poliomyelitis) Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global Polio (Poliomyelitis) Vaccines Sales Market Share by Application (2017-2028)
5.2 Global Polio (Poliomyelitis) Vaccines Revenue by Application
5.2.1 Global Polio (Poliomyelitis) Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global Polio (Poliomyelitis) Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global Polio (Poliomyelitis) Vaccines Price by Application
5.3.1 Global Polio (Poliomyelitis) Vaccines Price by Application (2017-2022)
5.3.2 Global Polio (Poliomyelitis) Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Polio (Poliomyelitis) Vaccines Market Size by Type
6.1.1 North America Polio (Poliomyelitis) Vaccines Sales by Type (2017-2028)
6.1.2 North America Polio (Poliomyelitis) Vaccines Revenue by Type (2017-2028)
6.2 North America Polio (Poliomyelitis) Vaccines Market Size by Application
6.2.1 North America Polio (Poliomyelitis) Vaccines Sales by Application (2017-2028)
6.2.2 North America Polio (Poliomyelitis) Vaccines Revenue by Application (2017-2028)
6.3 North America Polio (Poliomyelitis) Vaccines Market Size by Country
6.3.1 North America Polio (Poliomyelitis) Vaccines Sales by Country (2017-2028)
6.3.2 North America Polio (Poliomyelitis) Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Polio (Poliomyelitis) Vaccines Market Size by Type
7.1.1 Europe Polio (Poliomyelitis) Vaccines Sales by Type (2017-2028)
7.1.2 Europe Polio (Poliomyelitis) Vaccines Revenue by Type (2017-2028)
7.2 Europe Polio (Poliomyelitis) Vaccines Market Size by Application
7.2.1 Europe Polio (Poliomyelitis) Vaccines Sales by Application (2017-2028)
7.2.2 Europe Polio (Poliomyelitis) Vaccines Revenue by Application (2017-2028)
7.3 Europe Polio (Poliomyelitis) Vaccines Market Size by Country
7.3.1 Europe Polio (Poliomyelitis) Vaccines Sales by Country (2017-2028)
7.3.2 Europe Polio (Poliomyelitis) Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Polio (Poliomyelitis) Vaccines Market Size by Type
8.1.1 Asia Pacific Polio (Poliomyelitis) Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Polio (Poliomyelitis) Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Polio (Poliomyelitis) Vaccines Market Size by Application
8.2.1 Asia Pacific Polio (Poliomyelitis) Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific Polio (Poliomyelitis) Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific Polio (Poliomyelitis) Vaccines Market Size by Region
8.3.1 Asia Pacific Polio (Poliomyelitis) Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Polio (Poliomyelitis) Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Polio (Poliomyelitis) Vaccines Market Size by Type
9.1.1 Latin America Polio (Poliomyelitis) Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Polio (Poliomyelitis) Vaccines Revenue by Type (2017-2028)
9.2 Latin America Polio (Poliomyelitis) Vaccines Market Size by Application
9.2.1 Latin America Polio (Poliomyelitis) Vaccines Sales by Application (2017-2028)
9.2.2 Latin America Polio (Poliomyelitis) Vaccines Revenue by Application (2017-2028)
9.3 Latin America Polio (Poliomyelitis) Vaccines Market Size by Country
9.3.1 Latin America Polio (Poliomyelitis) Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Polio (Poliomyelitis) Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Polio (Poliomyelitis) Vaccines Market Size by Type
10.1.1 Middle East and Africa Polio (Poliomyelitis) Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Polio (Poliomyelitis) Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Polio (Poliomyelitis) Vaccines Market Size by Application
10.2.1 Middle East and Africa Polio (Poliomyelitis) Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Polio (Poliomyelitis) Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa Polio (Poliomyelitis) Vaccines Market Size by Country
10.3.1 Middle East and Africa Polio (Poliomyelitis) Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Polio (Poliomyelitis) Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Polio (Poliomyelitis) Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sanofi Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Overview
11.2.3 GSK Polio (Poliomyelitis) Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GSK Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GSK Recent Developments
11.3 Bibcol
11.3.1 Bibcol Corporation Information
11.3.2 Bibcol Overview
11.3.3 Bibcol Polio (Poliomyelitis) Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bibcol Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bibcol Recent Developments
11.4 Serum Institute
11.4.1 Serum Institute Corporation Information
11.4.2 Serum Institute Overview
11.4.3 Serum Institute Polio (Poliomyelitis) Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Serum Institute Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Serum Institute Recent Developments
11.5 Tiantan Biological
11.5.1 Tiantan Biological Corporation Information
11.5.2 Tiantan Biological Overview
11.5.3 Tiantan Biological Polio (Poliomyelitis) Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Tiantan Biological Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Tiantan Biological Recent Developments
11.6 IMBCA
11.6.1 IMBCA Corporation Information
11.6.2 IMBCA Overview
11.6.3 IMBCA Polio (Poliomyelitis) Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 IMBCA Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 IMBCA Recent Developments
11.7 Panacea Biotec Ltd
11.7.1 Panacea Biotec Ltd Corporation Information
11.7.2 Panacea Biotec Ltd Overview
11.7.3 Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Panacea Biotec Ltd Recent Developments
11.8 Bio-Med
11.8.1 Bio-Med Corporation Information
11.8.2 Bio-Med Overview
11.8.3 Bio-Med Polio (Poliomyelitis) Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Bio-Med Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bio-Med Recent Developments
11.9 Halfkin Bio-Pharmaceuticals
11.9.1 Halfkin Bio-Pharmaceuticals Corporation Information
11.9.2 Halfkin Bio-Pharmaceuticals Overview
11.9.3 Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Halfkin Bio-Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Polio (Poliomyelitis) Vaccines Industry Chain Analysis
12.2 Polio (Poliomyelitis) Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Polio (Poliomyelitis) Vaccines Production Mode & Process
12.4 Polio (Poliomyelitis) Vaccines Sales and Marketing
12.4.1 Polio (Poliomyelitis) Vaccines Sales Channels
12.4.2 Polio (Poliomyelitis) Vaccines Distributors
12.5 Polio (Poliomyelitis) Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Polio (Poliomyelitis) Vaccines Industry Trends
13.2 Polio (Poliomyelitis) Vaccines Market Drivers
13.3 Polio (Poliomyelitis) Vaccines Market Challenges
13.4 Polio (Poliomyelitis) Vaccines Market Restraints
14 Key Findings in The Global Polio (Poliomyelitis) Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer